Investor Ideas #Potcasts: #Cannabis News and #Stocks on the Move; (TSXV: $VIVO.V) (CSE: $DIXI_U.C) (NYSE: $ACB) (CSE: $CBIS.C) (CSE: $MYM.C)
Delta, Kelowna, BC – April 25, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at https://www.investorideas.com/news/2019/cannabis-potcasts/04251VIVO-DIXI-ACB-CBIS-MYM.asp
Today’s podcast overview/transcript:
Good afternoon and welcome to the 200th episode of Investorideas.com “potcast”, looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.
As this is our 200th episode we’d like to thank all of our interview guests who have come on before and of course you the listeners for sticking around this long. As we’ve reached this milestone I’m happy to announce that we will soon be adding new features such as product reviews and video interviews along with our continued daily announcements and interviews. If you’re working in the cannabis industry, no matter how big or small the role, please get in touch with us so we can help share your story and give our audience more ideas worth investing in.
Today we are looking at announcements from VIVO Cannabis Inc. (TSX-V: VIVO) (OTCQB: VVCIF), Dixie Brands (CSE: DIXI.U), (OTC: DXBRF), Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB), Valens GroWorks Corp. (CSE: VGW) (OTC: VGWCF), Cannabis One Holdings Inc. (CSE:CBIS) and MYM Nutraceuticals Inc., (CSE: MYM) (OTCBB: MYMMF).
VIVO Cannabis Inc. (TSX-V: VIVO) (OTCQB: VVCIF) today announced that its wholly-owned subsidiary, Canna Farms Limited, has received local municipal approval for its Phase 5 expansion which will add an incremental 2,500 kilograms of indoor capacity to its facility in Hope, B.C.
Canna Farms' Phase 5 expansion, originally slated to begin construction in 2020, is now expected to be completed in late 2019 or early 2020, pending regulatory approval. The expansion consists of 10,000 square feet of cultivation space, with expected capital costs of $3.5 million and is expected to bring VIVO's total internal production capacity to 13,500 kilograms by early 2020.
"Canna Farms is a cultivator and purveyor of premium quality, award winning, small-batch craft cannabis with widespread recognition and appeal as evidenced by its award for 'Top Reviewed Licensed Producer of the Year' at the 2018 Canadian Cannabis Awards," said Barry Fishman, Chief Executive Officer of VIVO. "This expansion will further increase Canna Farms' production capacity to help meet the significant market demand for premium B.C. dry bud. This project represents a strategic deployment of a minor portion of our strong cash position as the Company continues to invest to drive future growth."
Dixie Brands (CSE: DIXI.U), (OTC: DXBRF), one of the cannabis industry's leading consumer packaged goods companies, today announces a partnership with FounderMade to exclusively host the "Future of CBD & Cannabis" lounge at the FounderMade Discovery Show in New York City this coming June. Renowned for creating an environment where bold, innovative, life-changing products can thrive, the FounderMade Discovery Show is a summit for next generation companies to showcase groundbreaking products to key industry players.
A pioneer in the category for the past ten years, Dixie's Future of CBD & Cannabis lounge will champion the cannabis plant and spotlight the industry as it emerges from prohibition and enters the mainstream. As part of the showcase, Dixie will provide hands-on experiences and educate attendees on its full portfolio of THC and CBD-infused products, including hemp-derived CBD cosmeceutical brand, Kuida™, developed to bring the benefits of CBD to a comprehensive portfolio of skin and body care products for women. Once approved by the regulatory authorities, Kuida will be launched stateside via an exclusive distribution partnership between Dixie and Khiron Life Sciences, subject to TSX approval.
At the Future of CBD & Cannabis lounge, in addition to learning about Dixie's robust portfolio of Dixie Brands THC and CBD-infused products, event attendees will have the opportunity to engage with Aceso™ Hemp, Dixie's growing line of indication-specific, hemp-derived supplements that promote optimal health. As one of the first entrants into the category, Aceso Hemp brings a deep understanding of the industry's complex regulatory structure and expertise in the production of safe, effective and compliant products that can be sold across the United States.
Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB), announced today that the company has signed a binding share purchase agreement whereby Aurora has acquired all of the issued and outstanding common shares of privately-held Chemi Pharmaceutical Inc., an Ontario-based laboratory specialized in providing high quality analytics services to the pharmaceutical and cannabis industries, in a cash and share transaction comprised of an undisclosed cash payment and share consideration of 83,299 shares paid on closing and 41,649 payable upon achievement of certain Chemi milestones.
Chemi has a Health Canada Drug Establishment Licence enabling them to perform certified GMP compliant quality control analytical testing. In addition, Chemi has received US FDA accreditation for their facility, which is the gold standard for global pharmaceutical testing. Acquiring Chemi with their Drug Establishment Licence provides a critical prerequisite for applying for a Cannabis Drug Licence, which is required for the development of cannabis therapies within the global medical cannabis market.
Strategically located adjacent to Pearson Airport in Mississauga, Ontario, Chemi provides specialized cannabis testing across a broad set of parameters, including cannabinoid and terpene content. Chemi will be integrated into the Company's wholly owned subsidiary, Anandia Laboratories Inc. ("Anandia"), expanding Anandia's leading analytics capabilities to meet client demand and diversifying its specialized testing services for both the medical and the upcoming edible and derivatives markets.
Following the acquisition of Anandia in August 2018, Aurora integrated Anandia's plant science operations into the Company's broader science team, enabling Anandia to maintain independence as an analytical service provider, with its operations run at arm's length to ensure client confidentiality.
As the Canadian cannabis industry matures, the cultivation and processing operations of licensed producers, including Aurora, have developed rapidly to meet the growing demand from medical patients and consumers alike. Expanding Anandia's analytical testing footprint will enable it to service a broader base of domestic and international clients while ensuring continued timelines and quality of its testing services for existing clients.
Valens GroWorks Corp. (CSE: VGW) (OTC: VGWCF), a multi-licensed, vertically integrated provider of cannabis products and services focused on various proprietary extraction methodologies, distillation, cannabinoid isolation and purification, as well as associated quality testing announced that it has entered into an arm's length binding multi-year extraction services agreement to provide cannabis and hemp extraction services to HEXO Corp (TSX: HEXO) (NYSE-A: HEXO), a leading cannabis producer and consumer packaged goods cannabis company.
The Agreement has an initial 2-year term from the date of the first shipment, with HEXO supplying Valens with an annual minimum of 30,000kg in the first year and 50,000kg in the second year of cannabis and hemp biomass. Valens will process this material on a fee for service basis into premium quality resins and distillates using the Company's leading proprietary extraction processing methods. The Agreement contains provisions under which it may be terminated with 90 days written notice after the one-year anniversary. Valens expects to receive and begin processing the first shipment from HEXO early in Q3 of 2019 and currently holds all required licensing from Health Canada to carry out its obligations under the Agreement.
Cannabis One Holdings Inc. (CSE:CBIS), an emerging, premier "House of Brands" in North America, announced that it has entered into a letter agreement with Colorado-based cannabis industry consulting firm Itachi Advisory Group LLC, to pursue acquisitions related to a suite of portfolio assets related to cannabis retail, cultivation, and manufacturing operations from certain entities advised by Itachi.
On execution of the Agreement, Jeffery Mascio, CEO of Cannabis One, stated, "We believe this new partnership with Itachi will provide CBIS with a profound opportunity to explore the acquisition of a series of accretive transactions designed to rapidly expand our cannabis-related infrastructure." Mr. Mascio continued, "We believe that Neil Demers and his team at Itachi have identified a host of attractive assets for Cannabis One to consider and we look forward to evaluating each opportunity independently, on its merits, but with the express intention of moving towards a definitive agreement with each party as quickly as may be practicable."
MYM Nutraceuticals Inc. (CSE: MYM) (OTCBB: MYMMF). announced the formation of a Nevada Company, MYM One World LLC, to facilitate the joint multi-year co-operative agreement between MYM and Aqueous Sciences, a subsidiary of One World Ventures Inc. The company's mandate is to cultivate, extract & distribute 3,000 acres of hemp on Navajo Nation land located near the four corners area of Colorado, Arizona, Utah and New Mexico, USA.
The purpose of organizing a new company to cultivate, extract, and distribute hemp is so each corporation will own 50%. MYM and Aqueous also plan to extend their activities to include the extraction, manufacture and distribution of hemp based products that will comply with Navajo Nation, USDA, FDA and FTC regulations and requirements.
"Our partnership with Aqueous to cultivate 3,000 acres of CBD-rich hemp has taken another step forward today with the formation of MYM One World LLC," said Howard Steinberg, CEO of MYM. "Our team is currently preparing the fields for the 2019 growing season. We're looking forward to exceeding the results of last year's test crop that was successful in growing an abundance of CBD-rich hemp."
Lastly if you happen to be in the Toronto area, O'Cannabiz, Canada's leading business-focused cannabis conference and expo, kicks off today at Toronto's International Centre with a powerful opening keynote from rocker-turned-cannabis advocate Henry Rollins.
Tune in tomorrow for more cannabis news, as well as a special piece on 420 and my interview with Dooma Wenschuh, Co-Founder and CEO of Province Brands where we discuss cannabis beverages and what we can expect to see regarding regulations in Canada this October.
Investorideas also wishes to mention that starting next week we will be starting our CleanTech and Climate Change Podcast to help bring more ideas worth investing in.
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
